Simplify Logo

Full-Time

Executive Assistant

Confirmed live in the last 24 hours

Vaxcyte

Vaxcyte

201-500 employees

Develops vaccines for bacterial infections

Biotechnology
Healthcare

Compensation Overview

$132k - $145kAnnually

+ Equity Component

Expert

San Carlos, CA, USA

Category
Executive Support
Administrative & Executive Assistance
Required Skills
Communications
PowerPoint/Keynote/Slides
Requirements
  • Bachelor's degree with a minimum of 10 years’ experience supporting executive level leaders, preferably in the Biotech or Life Science field.
  • Exceptional organizational skills that reflect the ability to perform and prioritize multiple tasks seamlessly with attention to detail.
  • Strong interpersonal skills and the ability to build relationships. Demonstrates emotional maturity and a track record of developing strong credibility and trust with all levels within the organization.
  • Exceptional communication skills, both written and verbal.
  • Proven project management skills with experience driving internal and external events and business deliverables.
  • Solutions-oriented individual who can detect problems early and actively seeks opportunities and proposes creative and practical solutions.
  • Resourceful with ability to be effective working independently or as part of a project team.
  • Proven ability to handle confidential information with discretion and discernment and demonstrate the highest level of customer/client service and response.
  • Demonstrated ability to achieve high-performance goals and meet deadlines while managing changing or competing demands. Thrives in a fast-paced, growing organization.
  • Proficient in Microsoft Office (Outlook, Word, Excel, and PowerPoint), Zoom.
  • Ability to work onsite 3 days a week required.
Responsibilities
  • Be the executive’s force multiplier:
  • Optimize and ensure their preparation and effectiveness.
  • Anticipate and manage meeting, travel other logistical demands.
  • Proactively and strategically manage their calendar, prioritize and update based on solid understanding of the context for requests.
  • Understand and help prioritize key strategic initiatives and tasks.
  • Represent Vaxcyte to several external constituents.
  • Attend important meetings, take notes and manage follow-up.
  • Organize and execute team functions such as team building, and offsite events as requested.
  • Build cross-functional relationships at all levels of the Company to ensure understanding of the business, leaders and workflow.
  • Collaborate and partner closely other EAs regarding company-wide activities, cross-functional meetings, etc.
  • Engage in company-wide culture team activities, including logistical support.
  • Develop an understanding of the team and field requests from all contacts, making a point to be available and approachable.
  • Provide ad-hoc support as requested to individuals across the executives’ teams.
  • Demonstrate composure and flexibility, regardless of competing priorities.
  • Find new and efficient ways to create work processes to help maximize your executives' time, including weekly reporting, goal-tracking and team meetings.
  • Manage, and assist them in managing, teams across multiple domestic and international time zones.

Vaxcyte develops vaccines aimed at preventing bacterial infections, focusing on diseases like invasive pneumococcal disease, Group A Strep, periodontitis, and Shigella. Their lead product, VAX-24, is a pneumococcal conjugate vaccine that targets 24 strains of the Streptococcus pneumoniae bacteria and has received Breakthrough Therapy designation from the FDA. Vaxcyte utilizes advanced chemistry and a proprietary cell-free protein synthesis platform, XpressCF™, to create vaccines that can effectively address the complex defenses of bacteria while stimulating an immune response. This method sets them apart from traditional cell-based vaccine production. The company's goal is to develop and commercialize broad-spectrum vaccines to protect vulnerable populations from serious bacterial infections.

Company Stage

IPO

Total Funding

$2.3B

Headquarters

Foster City, California

Founded

2013

Growth & Insights
Headcount

6 month growth

24%

1 year growth

53%

2 year growth

114%
Simplify Jobs

Simplify's Take

What believers are saying

  • Significant investments from major financial entities like Vanguard and Mutual of America Capital Management indicate strong market confidence in Vaxcyte's potential.
  • The recent $816.5 million raised through stock and warrant sales provides substantial capital for advancing their vaccine pipeline.
  • The appointment of experienced board members like John Furey can provide strategic guidance and enhance corporate governance.

What critics are saying

  • The success of Vaxcyte heavily depends on the clinical and commercial success of its lead product, VAX-24, which is still subject to regulatory approval.
  • The competitive landscape in vaccine development is intense, with numerous established players potentially overshadowing Vaxcyte's market entry.

What makes Vaxcyte unique

  • Vaxcyte leverages its proprietary XpressCF™ cell-free protein synthesis platform, which allows for more efficient and versatile vaccine production compared to traditional cell-based methods.
  • Their focus on broad-spectrum vaccines, such as VAX-24 targeting 24 strains of Streptococcus pneumoniae, sets them apart in the vaccine development landscape.
  • The FDA Breakthrough Therapy designation for VAX-24 underscores the innovative potential and clinical significance of their lead product.